Alternative Dosing Schedule of Palbociclib in Metastatic Hormone Receptor Positive Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Breast Carcinoma|Cancer of Breast|Malignant Tumor of Breast
Interventions: DRUG: Palbociclib|DRUG: Letrozole|DRUG: Fulvestrant|PROCEDURE: Optional research biopsy|DRUG: Goserelin|PROCEDURE: Research blood draw|PROCEDURE: Circulating tumor cell blood draw|PROCEDURE: Tumor biopsy (optional)
Sponsor: Washington University School of Medicine
Collaborators: Pfizer